VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 112 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,291,000 | – | 229,818 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,791,805 | $64,992,000 | 3.92% |
| Birchview Capital, LP | 80,000 | $1,371,000 | 0.93% |
| Profit Investment Management, LLC | 78,154 | $1,339,000 | 0.93% |
| Soleus Capital Management, L.P. | 298,600 | $5,118,000 | 0.80% |
| GLOBEFLEX CAPITAL L P | 196,026 | $3,360,000 | 0.73% |
| DENALI ADVISORS LLC | 89,300 | $1,531,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 1,965,000 | $33,680,000 | 0.57% |
| FinTrust Capital Advisors, LLC | 105,982 | $1,816,000 | 0.48% |
| Zebra Capital Management LLC | 22,878 | $392,000 | 0.48% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 124,000 | $2,125,000 | 0.47% |